T. Rowe Price Associates »

Caris Life Sciences shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $78M 4.4M 17.89
2025-12-31 $130M 4.8M 26.98
2025-09-30 $210M 6.9M 30.25
2025-06-30 $181M 6.8M 26.72

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Caris Life Sciences

FMR
J. H. Whitney Equity Partners VI
Sixth Street Partners Management Company
Coatue Management
Braidwell
PointState Capital
BlackRock
T. Rowe Price Associates
Vanguard Portfolio Management
Neuberger Berman Group
Vanguard Capital Management
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"
Duquesne Family Office

View all funds holding Caris Life Sciences